Viveon Health Acquisition Corp.
AMEX:VHAQ
11.3 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Revenue
| 0 | 0 | 0 |
| Cost of Revenue
| 0.756 | 1.05 | 0 |
| Gross Profit
| -0.756 | -1.05 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 |
| General & Administrative Expenses
| 1.369 | 2.859 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 |
| SG&A
| 1.369 | 2.859 | 0.45 |
| Other Expenses
| 0 | 1.247 | -0.026 |
| Operating Expenses
| 2.371 | 4.106 | 0.45 |
| Operating Income
| -2.371 | -4.106 | -0.45 |
| Operating Income Ratio
| 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.946 | 6.596 | -1.788 |
| Income Before Tax
| -0.425 | 2.49 | -2.239 |
| Income Before Tax Ratio
| 0 | 0 | 0 |
| Income Tax Expense
| 0.061 | -0.02 | -0.001 |
| Net Income
| -0.487 | 2.49 | -2.239 |
| Net Income Ratio
| 0 | 0 | 0 |
| EPS
| -0.04 | 0.12 | -0.089 |
| EPS Diluted
| -0.04 | 0.12 | -0.089 |
| EBITDA
| 1.946 | -4.085 | -0.45 |
| EBITDA Ratio
| 0 | 0 | 0 |